Affiliation:
1. Department of Basic Medical Sciences, Neuroscience and Sensory Organs, University of Bari “Aldo Moro”, School of Medicine, Bari, Italy
Abstract
Over the past 20 years, Endocrine Metabolic Immune Disorders-Drug Targets (EMIDDT)
journal has been covering a broad field of intertwined topics related to pathogenesis, diagnosis,
and therapy of endocrine, metabolic, and immune diseases. At first, the journal publications
were restricted to reviews only and, then, original article submissions have also been accepted.
EMIDDT represents as a successful journal in continuous expansion with 10 issues in 2020 and a
current impact factor (IF) equal to 1.973. Moreover, since 2019, EMIDDT is the official journal of
the Italian AME (Associazione Medici Endocrinologi), also linked to the American Association of
Endocrinologists. Such a connection has given more impetus to the journal in terms of additional
higher-quality submissions. In order to celebrate the 20th anniversary of EMIDDT, the content of
some original representative articles published by the journal in the past and current years will be illustrated
with special emphasis on cellular and molecular bases of drug targeting.
Publisher
Bentham Science Publishers Ltd.
Subject
Immunology and Allergy,Endocrinology, Diabetes and Metabolism
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genome Editing and Fatty Liver;Advances in Experimental Medicine and Biology;2022-12-02